BREVICON 0.5/35 TABLETS (28-DAY PACK)
Identification of Brevicon 0.5/35 Tablets (28-Day Pack)
| No description |
Google image searchProduct monograph
Active ingredients
ethinyl estradiol, .035 MG
norethindrone, .5 MG
DIN: 02187094
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 18-APR-2006
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03A — HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, ATC/DDD)
- G03AA — Progestogens and estrogens, fixed combinations (ATC, ATC/DDD)
- G03AA05 — NORETHISTERONE AND ESTROGEN (ATC/DDD)
Reference brand drug: Brevicon, Select
Pharmaceutical standard: USP
